JPH1066585A - ヒト軟骨糖蛋白質 - Google Patents

ヒト軟骨糖蛋白質

Info

Publication number
JPH1066585A
JPH1066585A JP9152775A JP15277597A JPH1066585A JP H1066585 A JPH1066585 A JP H1066585A JP 9152775 A JP9152775 A JP 9152775A JP 15277597 A JP15277597 A JP 15277597A JP H1066585 A JPH1066585 A JP H1066585A
Authority
JP
Japan
Prior art keywords
protein
sequence
nucleic acid
encoding
polypeptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP9152775A
Other languages
English (en)
Japanese (ja)
Other versions
JPH1066585A5 (enExample
Inventor
Robert B Kirkpatrick
ロバート・ビー・キルクパトリック
Martin Rosenberg
マーティン・ローゼンバーグ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Publication of JPH1066585A publication Critical patent/JPH1066585A/ja
Publication of JPH1066585A5 publication Critical patent/JPH1066585A5/ja
Withdrawn legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6887—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2405—Glucanases
    • C12N9/2434—Glucanases acting on beta-1,4-glucosidic bonds
    • C12N9/2442—Chitinase (3.2.1.14)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01014—Chitinase (3.2.1.14)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/924—Hydrolases (3) acting on glycosyl compounds (3.2)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP9152775A 1996-05-03 1997-05-06 ヒト軟骨糖蛋白質 Withdrawn JPH1066585A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1653296P 1996-05-03 1996-05-03
US60/016532 1996-05-03

Publications (2)

Publication Number Publication Date
JPH1066585A true JPH1066585A (ja) 1998-03-10
JPH1066585A5 JPH1066585A5 (enExample) 2005-04-07

Family

ID=21777606

Family Applications (1)

Application Number Title Priority Date Filing Date
JP9152775A Withdrawn JPH1066585A (ja) 1996-05-03 1997-05-06 ヒト軟骨糖蛋白質

Country Status (3)

Country Link
US (2) US6576427B1 (enExample)
EP (1) EP0805206A3 (enExample)
JP (1) JPH1066585A (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7229770B1 (en) * 1998-10-01 2007-06-12 The Regents Of The University Of California YKL-40 as a marker and prognostic indicator for cancers
CA2164498C (en) 1993-07-09 2007-09-11 Paul A. Price Assay for ykl-40 as a marker for degradation of mammalian connective tissue matrices
EP0805206A3 (en) 1996-05-03 1999-09-15 Smithkline Beecham Corporation Human cartilage glycoprotein
US5811535A (en) * 1996-08-09 1998-09-22 Smithkline Beecham Corporation Human cartilege gp39-like gene
TR200100175T2 (tr) * 1998-07-23 2001-09-21 Akzo Nobel N.V. Otoimmün hastalıkların immünoterapisinde kullanılmak üzere yeni peptitler.
JP2002521344A (ja) * 1998-07-23 2002-07-16 アクゾ・ノベル・エヌ・ベー 免疫疾患におけるＨＣｇｐ−３９の使用
CA2454342A1 (en) * 2001-07-24 2003-02-06 Yale University Methods, compositions and kits relating to chitinases and chitinase-like molecules and inflammatory disease
EP1729805A4 (en) * 2004-02-25 2008-11-26 Medimmune Inc METHODS AND COMPOSITIONS RELATED TO CHITINASES AND CHITINASE-MOLECULARS AND MODULATION OF OSTEOCLASTS
WO2007027748A2 (en) * 2005-08-31 2007-03-08 Medimmune, Inc. C/clp antagonists and methods of use thereof
US8377650B2 (en) * 2006-03-17 2013-02-19 The Norwegian University Of Life Sciences (Umb) Method of enhancing degradation of chitin
EP2245459A1 (en) * 2008-01-23 2010-11-03 Herlev Hospital Ykl-40 as a general marker for non-specific disease
AU2009207923A1 (en) * 2008-01-23 2009-07-30 Rigshospitalet Classification of individuals suffering from cardiovascular diseases according to survival prognoses as found by measuring the levels of biomarker YKL-40
AU2009291312A1 (en) 2008-09-15 2010-03-18 Herlev Hospital YKL-40 as a marker for gastrointestinal cancers

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5928928A (en) * 1995-06-07 1999-07-27 Universiteit Van Amsterdam Human chitinase, its recombinant production, its use for decomposing chitin, its use in therapy or prophylaxis against infection diseases
EP0805206A3 (en) 1996-05-03 1999-09-15 Smithkline Beecham Corporation Human cartilage glycoprotein
US5811535A (en) 1996-08-09 1998-09-22 Smithkline Beecham Corporation Human cartilege gp39-like gene
WO1998006859A1 (en) * 1996-08-09 1998-02-19 Human Genome Sciences, Inc. Human chitinase alpha and chitinase alpha-2

Also Published As

Publication number Publication date
EP0805206A2 (en) 1997-11-05
US7067280B2 (en) 2006-06-27
EP0805206A3 (en) 1999-09-15
US20030215847A1 (en) 2003-11-20
US6576427B1 (en) 2003-06-10

Similar Documents

Publication Publication Date Title
US6495519B1 (en) Interleukin-1 β converting enzyme like apoptosis protease-3 and 4
US5811535A (en) Human cartilege gp39-like gene
EP1380594A1 (en) Fibroblast growth factor-10
JP2002510462A (ja) 哺乳類のエンドグルクロニダーゼをコードする単離された核酸分子およびその使用
US7067280B2 (en) Human cartilage glycoprotein
US6461848B1 (en) Human heparanase polypeptide and cDNA
US6083700A (en) Human goose-type lysozyme
WO1997035037A1 (en) Tissue remodeling proteins
US6602984B1 (en) Human elastase IV
US20030083254A1 (en) Substances
US6835555B1 (en) Interleukin-1 β converting enzyme like apoptosis protease-3 and 4
JPH11508139A (ja) キトトリオシダーゼ
US20040171535A1 (en) Heparanase II, a novel human heparanase paralog
US20040072292A1 (en) Human g-type lysozyme, the encoding sequence, preparing method and the uses thereof
JPH10201489A (ja) ｈＲＡＤ５４
JPH10501966A (ja) ヒトｄｎａトポイソメラーゼｉ−アルファ
US20030166863A1 (en) Macrophage migration inhibitory factor-3
JPH10508484A (ja) ヒトｄｎａリガーゼｉｉｉ
MXPA97000151A (en) Elastase iv hum
WO2001075042A2 (fr) Nouveau polypeptide, serine hydrolase humaine atp-dependante 9, et polynucleotide codant pour ce polypeptide
WO2001048206A1 (fr) Nouveau polypeptide, facteur d'inhibition de proteinase humain 12, et polynucleotide codant pour ce polypeptide
JP2002020313A (ja) ヒトｄｎａトポイソメラーゼｉ−アルファ

Legal Events

Date Code Title Description
A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20040506

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20040506

A761 Written withdrawal of application

Free format text: JAPANESE INTERMEDIATE CODE: A761

Effective date: 20060314